Ask the Expert: Q&A on Breast Cancer, Exercise and Diet

Dana-Farber Cancer Institute’s Jennifer Ligibel, MD, recently partnered with CancerConnect to answer questions about breast cancer, exercise and diet. Ligibel is an oncologist with the Susan F. Smith Center for Women’s Cancers at Dana-Farber. Q: I am currently on maintenance treatment for breast cancer and I need to lose weight. Do you have any tips … Read more

50 Years of Discovery: Advances in Colorectal Cancer Treatment

The fight against cancers of the digestive system – including colorectal, stomach, esophageal, hepatic, and pancreatic cancers – has made significant progress in the past 50 years, especially in prevention and early diagnosis of colorectal cancer, where screening with tests such as colonoscopies is continuing to make a major impact. “In some areas we have done … Read more

Webchat: The Latest in Breast Cancer Treatment and Research

With new approaches to therapy and increased understanding of the biology of cancer, breast cancer treatment has made significant progress in recent years. “I am personally very excited about what’s to come for breast cancer treatment,” says Eric Winer, MD, director of the Breast Oncology Program in the Susan F. Smith Center for Women’s Cancers … Read more

What is a Meningioma?

A meningioma is a type of tumor that develops from the meninges, the membrane that surrounds the brain and spinal cord. Most meningiomas (90 percent) are categorized as benign tumors, with the remaining 10 percent being atypical or malignant. In many cases, benign meningiomas grow slowly. This means that depending upon where it is located, … Read more

What Does No Hair Loss During Chemo Mean?

Medically reviewed by Clare Sullivan, BSN, MPH, CRRN It’s well known that many chemotherapy medications used to treat cancer can bring undesirable side effects, such as hair loss, lack of appetite, and fatigue. But experiencing such symptoms is not an indication of whether cancer treatment is working. How does chemotherapy affect cells? Chemotherapy interferes with … Read more

‘Chemobrain’ Added to Cancer Survivorship Guidelines

Cognitive dysfunction is a common and frustrating side effect for many patients who undergo chemotherapy. The condition – also called “chemobrain” – can create problems with memory, attention and concentration, information processing, and mental skills used for organizing and scheduling. For many years, medical professionals were skeptical that these cognitive issues were a real side effect of … Read more

Precision Medicine for Lung Cancer Marks Tenth Anniversary

Ten years ago researchers at Dana-Farber and in Japan published a study showing that lung cancer patients whose tumors had a malfunctioning version of a protein called Epidermal Growth Factor Receptor (EGFR) responded dramatically to a drug that specifically targets the EGFR protein. The findings launched the era of precision medicine for lung cancer, transforming … Read more

New Experimental Breast Cancer Drug Shows Promise

Reports of an experimental drug that slowed advanced breast cancer in a clinical trial have stirred excitement at a national research meeting and breathed new life into a cancer-fighting strategy that had seemed to falter. In one study, the drug, palbociclib, doubled the length of time without disease progression in patients with metastatic estrogen receptor-positive breast … Read more

Does Talcum Powder Cause Ovarian Cancer? Here’s The Latest

It’s been suggested that regular use of talcum powder products in the genital area might increase the possibility of ovarian cancer. In theory, particles of talc could travel through the reproductive tract to the ovaries and cause cancer. Research on this potential link has yielded mixed findings, with some studies finding a small increase in risk. … Read more

Living Life

By Jack Coates

In May 2001, I was diagnosed with medulloblastoma. I was 19 years old and had just finished my freshman year at Johnson & Wales University in Rhode Island.

Medulloblastoma is a cancer that affects the brain and the spine. I had three surgeries, 52 weeks of chemo, and six weeks of radiation. I spent a year and two months in the hospital and went from 217 pounds to 97. I was scared. I was asking God: “Why?  Why did it have to happen to me?” It was shocking. Many things went through my mind.

Read more

Clinical Trials Paving the Way for Improved Vulvar Cancer Treatment

Cancers of the vulva – the external portion of the female genitals – are diagnosed in approximately 4,700 women in the United States each year. While many patients can be cured by a combination of surgery, chemotherapy, and radiation therapy, others – particularly those whose cancer has metastasized to other parts of the body – often don’t fare as well.

As one of the rarer forms of gynecologic cancer, vulvar cancer hasn’t attracted as much research funding as other forms. Still, several efforts are under way to make treatment options more effective, according to Neil Horowitz, MD, a vulvar cancer expert at the Susan F. Smith Center for Women’s Cancers at Dana-Farber.

Read more